According to SNS Insider, the global RNAi Technology Market was valued at USD 3.02 billion in 2024 and is projected to reach USD 9.03 billion by 2032, expanding at a CAGR of 14.68% over 2025–2032. RNA ...

Received CTA authorization for Phase 1 trial of lead program AX-0810, targeting NTCP for cholestatic diseasesInitiating Phase ...

An update from Veritas In Silico Inc. ( ($JP:130A) ) is now available. Veritas In Silico Inc. and Dexerials Corporation have announced a joint ...

Researchers from the University of Eastern Finland and Aalto University have developed a computational framework called ...

Learn how advanced molecular dynamics simulations can improve RNA-based therapeutics by modeling complex folding processes.

SPT Labtech and Swiss company Alithea Genomics have announced a partnership for automating single-cell transcriptomic ...

Researchers at the University of Bonn have uncovered how a kidney RNA molecule can trigger autoimmune disease. In mice, a ...

SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and ...

The RNA Institute at the University at Albany is getting a $50 million expansion to help bring more discoveries to market.

Victorian researchers have developed a world-first RNA drug to prevent the damaging effects of lupus, marking a breakthrough ...

Seattle's Parse Biosciences is teed up for an acquisition by Qiagen, a Netherlands-based holding company, in a $225 million ...

Oxford Nanopore is moving ahead with plans for an initial public offering (IPO) and has now hired banks to manage the process, two sources familiar with the matter told Reuters, in a further boost to ...